Back to Journals » ImmunoTargets and Therapy » Volume 10

ImmunoTargets and Therapy


Archive: Volume 10, 2021

Pathophysiology of Non-IgE-Mediated Food Allergy

Zhang S, Sicherer S, Berin MC, Agyemang A

ImmunoTargets and Therapy 2021, 10:431-446

Published Date: 29 December 2021

Understanding and Managing Severe Asthma in the Context of COVID-19

Kong-Cardoso B, Ribeiro A, Aguiar R, Pité H, Morais-Almeida M

ImmunoTargets and Therapy 2021, 10:419-430

Published Date: 11 December 2021

The Role of IL-17 Cytokines in Psoriasis

Mosca M, Hong J, Hadeler E, Hakimi M, Liao W, Bhutani T

ImmunoTargets and Therapy 2021, 10:409-418

Published Date: 24 November 2021

The Role of Complement in Synaptic Pruning and Neurodegeneration

Gomez-Arboledas A, Acharya MM, Tenner AJ

ImmunoTargets and Therapy 2021, 10:373-386

Published Date: 24 September 2021

Immunotherapy of Multiple Myeloma: Promise and Challenges

Abramson HN

ImmunoTargets and Therapy 2021, 10:343-371

Published Date: 9 September 2021

Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis

Arneson LC, Carroll KJ, Ruderman EM

ImmunoTargets and Therapy 2021, 10:333-342

Published Date: 28 August 2021

Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma

Bughda R, Dimou P, D'Souza RR, Klampatsa A

ImmunoTargets and Therapy 2021, 10:313-323

Published Date: 5 August 2021

Alopecia Areata: An Autoimmune Disease of Multiple Players

Suchonwanit P, Kositkuljorn C, Pomsoong C

ImmunoTargets and Therapy 2021, 10:299-312

Published Date: 29 July 2021

Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology

Unterberger S, Davies KA, Rambhatla SB, Sacre S

ImmunoTargets and Therapy 2021, 10:285-298

Published Date: 28 July 2021

Complement Inhibition and COVID-19: The Story so Far

Fodil S, Annane D

ImmunoTargets and Therapy 2021, 10:273-284

Published Date: 26 July 2021

Cannabis and Autoimmunity: Possible Mechanisms of Action

Giorgi V, Marotto D, Batticciotto A, Atzeni F, Bongiovanni S, Sarzi-Puttini P

ImmunoTargets and Therapy 2021, 10:261-271

Published Date: 21 July 2021

The Cancer-Immunity Cycle in Multiple Myeloma

Casey M, Nakamura K

ImmunoTargets and Therapy 2021, 10:247-260

Published Date: 16 July 2021

Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era

Kasarello K, Mirowska-Guzel D

ImmunoTargets and Therapy 2021, 10:237-246

Published Date: 7 July 2021

Targeting CD22 for the Treatment of B-Cell Malignancies

Shah NN, Sokol L

ImmunoTargets and Therapy 2021, 10:225-236

Published Date: 6 July 2021

CD38-Directed Therapies for Management of Multiple Myeloma

Hashmi H, Husnain M, Khan A, Usmani SZ

ImmunoTargets and Therapy 2021, 10:201-211

Published Date: 29 June 2021

VISTA: A Promising Target for Cancer Immunotherapy?

Tagliamento M, Agostinetto E, Borea R, Brandão M, Poggio F, Addeo A, Lambertini M

ImmunoTargets and Therapy 2021, 10:185-200

Published Date: 22 June 2021

Memory Generation and Re-Activation in Food Allergy

Koenig JFE, Bruton K, Phelps A, Grydziuszko E, Jiménez-Saiz R, Jordana M

ImmunoTargets and Therapy 2021, 10:171-184

Published Date: 9 June 2021

NHS-IL12, a Tumor-Targeting Immunocytokine

Greiner JW, Morillon II YM, Schlom J

ImmunoTargets and Therapy 2021, 10:155-169

Published Date: 27 May 2021

Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis

Atzeni F, Carriero A, Boccassini L, D'Angelo S

ImmunoTargets and Therapy 2021, 10:141-153

Published Date: 3 May 2021

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy

Xu N, Tse B, Yang L, Tang TCY, Haber M, Micklethwaite K, Dolnikov A

ImmunoTargets and Therapy 2021, 10:123-140

Published Date: 28 April 2021

TNFR2: Role in Cancer Immunology and Immunotherapy

Yang Y, Islam MS, Hu Y, Chen X

ImmunoTargets and Therapy 2021, 10:103-122

Published Date: 21 April 2021

Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches

Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F

ImmunoTargets and Therapy 2021, 10:63-85

Published Date: 9 March 2021

Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent

Barros PO, Berthoud TK, Aloufi N, Angel JB

ImmunoTargets and Therapy 2021, 10:47-62

Published Date: 8 March 2021

Anti-IgE for the Treatment of Chronic Urticaria

Wedi B, Traidl S

ImmunoTargets and Therapy 2021, 10:27-45

Published Date: 17 February 2021

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

Passiglia F, Reale ML, Cetoretta V, Novello S

ImmunoTargets and Therapy 2021, 10:9-26

Published Date: 5 February 2021

Current Insights into Immunotherapy Approaches for Food Allergy

Macdougall JD, Burks AW, Kim EH

ImmunoTargets and Therapy 2021, 10:1-8

Published Date: 27 January 2021